A Systematic Review of Extracellular Matrix-Related Alterations in Parkinson's Disease

被引:1
|
作者
Chapman, Mary Ann [1 ]
Sorg, Barbara A. [2 ]
机构
[1] Visage Commun, Spokane, WA 99021 USA
[2] Legacy Res Inst, RS Dow Neurobiol, Portland, OR 97232 USA
基金
美国国家卫生研究院;
关键词
collagen; extracellular matrix; focal adhesion; cell adhesion; proteoglycan; glycosaminoglycan; matrisome; GENOME-WIDE ASSOCIATION; NIGRA PARS COMPACTA; ALPHA-SYNUCLEIN; UBIQUITIN-PROTEASOME; CHONDROITIN SULFATE; PATHWAY ANALYSIS; CELL-ADHESION; GROWTH-FACTOR; LEWY BODIES; EXPRESSION;
D O I
10.3390/brainsci14060522
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of the extracellular matrix (ECM) in Parkinson's disease (PD) is not well understood, even though it is critical for neuronal structure and signaling. This systematic review identified the top deregulated ECM-related pathways in studies that used gene set enrichment analyses (GSEA) to document transcriptomic, proteomic, or genomic alterations in PD. PubMed and Google scholar were searched for transcriptomics, proteomics, or genomics studies that employed GSEA on data from PD tissues or cells and reported ECM-related pathways among the top-10 most enriched versus controls. Twenty-seven studies were included, two of which used multiple omics analyses. Transcriptomics and proteomics studies were conducted on a variety of tissue and cell types. Of the 17 transcriptomics studies (16 data sets), 13 identified one or more adhesion pathways in the top-10 deregulated gene sets or pathways, primarily related to cell adhesion and focal adhesion. Among the 8 proteomics studies, 5 identified altered overarching ECM gene sets or pathways among the top 10. Among the 4 genomics studies, 3 identified focal adhesion pathways among the top 10. The findings summarized here suggest that ECM organization/structure and cell adhesion (particularly focal adhesion) are altered in PD and should be the focus of future studies.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Bioanalytical methods for circulating extracellular matrix-related proteins: new opportunities in cancer diagnosis
    Ramón Lorenzo-Gómez
    Rebeca Miranda-Castro
    Noemí de-los-Santos-Álvarez
    María Jesús Lobo-Castañón
    Analytical and Bioanalytical Chemistry, 2022, 414 : 147 - 165
  • [42] DIFFERENTIAL EXPRESSION OF EXTRACELLULAR MATRIX-RELATED GENES IN TISSUE OF STABLE AND UNSTABLE ATHEROSCLEROTIC PLAQUES
    Shakhtshneider, E.
    Ivanoshchuk, D.
    Fishman, V.
    Ragino, I.
    Polonskaya, Y. V.
    Kashtanova, E. V.
    Chernyavsky, A.
    Murashov, I.
    Voevoda, M.
    ATHEROSCLEROSIS, 2022, 355 : E110 - E110
  • [43] Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer
    Tiwari, Saumya
    Triulzi, Tiziana
    Holton, Sarah
    Regondi, Viola
    Paolini, Biagio
    Tagliabue, Elda
    Bhargava, Rohit
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [44] Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy
    Hicks, Debbie
    Farsani, Golara Torabi
    Laval, Steven
    Collins, James
    Sarkozy, Anna
    Martoni, Elena
    Shah, Ashoke
    Zou, Yaqun
    Koch, Manuel
    Boennemann, Carsten G.
    Roberts, Mark
    Lochmueller, Hanns
    Bushby, Kate
    Straub, Volker
    HUMAN MOLECULAR GENETICS, 2014, 23 (09) : 2353 - 2363
  • [45] Systematic review of biomarkers for disease progression in Parkinson's disease
    McGhee, D. J. M.
    Royle, P. L.
    Counsell, C. E.
    MOVEMENT DISORDERS, 2012, 27 : S128 - S129
  • [46] Brain microstructural alterations of depression in Parkinson's disease: A systematic review of diffusion tensor imaging studies
    Salehi, Mohammad Amin
    Mohammadi, Soheil
    Gouravani, Mahdi
    Javidi, Arian
    Dager, Stephen R.
    HUMAN BRAIN MAPPING, 2022, 43 (18) : 5658 - 5680
  • [47] Bioanalytical methods for circulating extracellular matrix-related proteins: new opportunities in cancer diagnosis
    Lorenzo-Gomez, Ramon
    Miranda-Castro, Rebeca
    De-los-Santos-alvarez, Noemi
    Lobo-Castanon, Maria Jesus
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2022, 414 (01) : 147 - 165
  • [48] SYSTEMATIC REVIEW OF BIOMARKERS FOR DISEASE PROGRESSION IN PARKINSON'S DISEASE
    McGhee, D.
    Counsell, C. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (03):
  • [49] SYSTEMATIC REVIEW OF BIOMARKERS FOR DISEASE PROGRESSION IN PARKINSON'S DISEASE
    McGhee, D. J. M.
    Royle, P. L.
    Counsell, C. E.
    AGE AND AGEING, 2013, 42 : 5 - 5
  • [50] A systematic review of biomarkers for disease progression in Parkinson’s disease
    David JM McGhee
    Pamela L Royle
    Paul A Thompson
    David E Wright
    John P Zajicek
    Carl E Counsell
    BMC Neurology, 13